These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of anaemia on long-term outcomes in patients treated with first- and second-generation drug-eluting stents; Katowice-Zabrze Registry. Wańha W, Kawecki D, Roleder T, Pluta A, Marcinkiewicz K, Dola J, Morawiec B, Krzych Ł, Pawłowski T, Smolka G, Ochała A, Nowalany-Kozielska E, Tendera M, Wojakowski W. Kardiol Pol; 2016; 74(6):561-9. PubMed ID: 26575311 [Abstract] [Full Text] [Related]
3. First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry). Kawecki D, Morawiec B, Dola J, Wanha W, Smolka G, Pluta A, Marcinkiewicz K, Ochała A, Nowalany-Kozielska E, Wojakowski W. Arq Bras Cardiol; 2016 May; 106(5):373-81. PubMed ID: 27058257 [Abstract] [Full Text] [Related]
4. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry. Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K. J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689 [Abstract] [Full Text] [Related]
5. Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry). Kawecki D, Morawiec B, Dola J, Wańha W, Smolka G, Pluta A, Marcinkiewicz K, Ochała A, Nowalany-Kozielska E, Wojakowski W. Med Sci Monit; 2015 Oct 27; 21():3261-9. PubMed ID: 26506478 [Abstract] [Full Text] [Related]
7. Long-Term Percutaneous Coronary Intervention Outcomes of Patients with Chronic Kidney Disease in the Era of Second-Generation Drug-Eluting Stents. Wańha W, Kawecki D, Roleder T, Pluta A, Marcinkiewicz K, Morawiec B, Dola J, Gładysz S, Pawłowski T, Smolka G, Ochała A, Nowalany-Kozielska E, Wojakowski W. Cardiorenal Med; 2017 Feb 27; 7(2):85-95. PubMed ID: 28611782 [Abstract] [Full Text] [Related]
8. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry. Abdel-Wahab M, Nienaber CA, Mostafa AE, Sabin G, Tebbe U, Hochadel M, Senges J, Akin I, Kuck KH, Hamm C, Richardt G, German Drug-Eluting Stent (DES.DE) registry. EuroIntervention; 2011 Jun 27; 7(2):201-8. PubMed ID: 21646062 [Abstract] [Full Text] [Related]
9. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Cassese S, Kufner S, Xhepa E, Byrne RA, Kreutzer J, Ibrahim T, Tiroch K, Valgimigli M, Tölg R, Fusaro M, Schunkert H, Laugwitz KL, Mehilli J, Kastrati A. Clin Res Cardiol; 2016 Jul 27; 105(7):575-84. PubMed ID: 26689707 [Abstract] [Full Text] [Related]
10. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease. Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E. Arch Cardiovasc Dis; 2013 Nov 27; 106(11):554-61. PubMed ID: 24231052 [Abstract] [Full Text] [Related]
13. Safety and efficacy outcomes of 3rd generation DES in an all-comer population of patients undergoing PCI: 12-month and 24-month results of the e-Biomatrix French registry. Maupas E, Lipiecki J, Levy R, Faurie B, Karsenty B, Moulichon ME, Brunelle F, Maillard L, de Poli F, Lefèvre T. Catheter Cardiovasc Interv; 2017 Nov 15; 90(6):890-897. PubMed ID: 28544186 [Abstract] [Full Text] [Related]
20. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. Pyxaras SA, Hunziker L, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A, Naber CK. EuroIntervention; 2016 Aug 05; 12(5):e623-31. PubMed ID: 27497362 [Abstract] [Full Text] [Related] Page: [Next] [New Search]